Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HSTC
HST Global
$0.00
$0.06
$0.00
$1.05
$14K-1.46N/AN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
$0.01
+4,900.0%
$0.00
$0.00
$1.01
$14K2.045,993 shs450 shs
Optec International, Inc. stock logo
OPTI
Optec International
$0.00
$0.00
$0.00
$0.00
$13KN/A1.05 million shs175,232 shs
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
$0.00
$0.00
$0.05
$4K1.94N/AN/A
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HSTC
HST Global
0.00%0.00%0.00%-99.96%-99.98%
NexImmune, Inc. stock logo
NEXI
NexImmune
0.00%+4,900.00%+4,900.00%+9,900.00%-97.37%
Optec International, Inc. stock logo
OPTI
Optec International
0.00%-26.67%-31.25%-31.25%+37.50%
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HSTC
HST Global
$0.00
$0.06
$0.00
$1.05
$14K-1.46N/AN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
$0.01
+4,900.0%
$0.00
$0.00
$1.01
$14K2.045,993 shs450 shs
Optec International, Inc. stock logo
OPTI
Optec International
$0.00
$0.00
$0.00
$0.00
$13KN/A1.05 million shs175,232 shs
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
$0.00
$0.00
$0.05
$4K1.94N/AN/A
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HSTC
HST Global
0.00%0.00%0.00%-99.96%-99.98%
NexImmune, Inc. stock logo
NEXI
NexImmune
0.00%+4,900.00%+4,900.00%+9,900.00%-97.37%
Optec International, Inc. stock logo
OPTI
Optec International
0.00%-26.67%-31.25%-31.25%+37.50%
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HSTC
HST Global
0.00
N/AN/AN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
0.00
N/AN/AN/A
Optec International, Inc. stock logo
OPTI
Optec International
0.00
N/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HSTC
HST Global
N/AN/AN/AN/AN/AN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
N/AN/AN/AN/A$3.32 per shareN/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HSTC
HST Global
-$150K-$0.02N/AN/AN/AN/AN/AN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
-$32.34M-$18.54N/AN/AN/A-534.32%-213.72%N/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/A0.00N/AN/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
HSTC
HST Global
N/AN/AN/AN/AN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
N/AN/AN/AN/AN/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HSTC
HST Global
N/AN/AN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
N/A
0.66
0.66
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
HSTC
HST Global
N/A
NexImmune, Inc. stock logo
NEXI
NexImmune
9.85%
Optec International, Inc. stock logo
OPTI
Optec International
N/A
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
N/A

Insider Ownership

CompanyInsider Ownership
HSTC
HST Global
65.82%
NexImmune, Inc. stock logo
NEXI
NexImmune
14.90%
Optec International, Inc. stock logo
OPTI
Optec International
50.34%
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
4.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
HSTC
HST Global
170.19 million23.99 millionNot Optionable
NexImmune, Inc. stock logo
NEXI
NexImmune
61.40 million1.19 millionNot Optionable
Optec International, Inc. stock logo
OPTI
Optec International
111.65 millionN/ANot Optionable
Sophiris Bio, Inc. stock logo
SPHS
Sophiris Bio
635.55 millionN/ANot Optionable

Recent News About These Companies

Wisr AI Systems Inc. Announces Closing of Amalgamation
Best Louisiana High Schools
BLTE - Belite Bio, Inc
Bio-Reference Laboratories
Sophiris Bio Inc. Registered Sh (BFF1.SG)
Pennsylvania Gov.-elect Josh Shapiro biography
Weapons news

New MarketBeat Followers Over Time

HST Global OTCMKTS:HSTC

$0.0002 0.00 (0.00%)
As of 09/12/2025

HST Global, Inc., operates as an integrated health and wellness biotechnology company in the United States. The company develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer and other life threatening diseases. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancer and or/ life threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.

NexImmune stock logo

NexImmune NASDAQ:NEXI

$0.01 +0.01 (+4,900.00%)
As of 09/12/2025 03:37 PM Eastern

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Optec International stock logo

Optec International OTCMKTS:OPTI

$0.0011 0.00 (0.00%)
As of 03:14 PM Eastern

Optec International, Inc. engages in selling and marketing optimized fuel maximizer units in North America and internationally. It markets optimized fuel maximizer for passenger vehicles, intermediate/medium duty trucks, off-road equipment, generator systems, heavy duty diesel on-road vehicles, and transportation refrigeration units. The company was formerly known as Green Meadow Products, Inc. and changed its name to Optec International, Inc. in August 2017. Optec International, Inc. was founded in 2012 and is based in Carlsbad, California.

Sophiris Bio stock logo

Sophiris Bio OTCMKTS:SPHS

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.